4/14
08:30 am
rnxt
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
Low
Report
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
4/9
08:15 am
rnxt
RenovoRx (RNXT) had its price target raised by Ascendiant Capital Markets from $13.00 to $13.50. They now have a "buy" rating on the stock.
Medium
Report
RenovoRx (RNXT) had its price target raised by Ascendiant Capital Markets from $13.00 to $13.50. They now have a "buy" rating on the stock.
4/8
12:48 pm
rnxt
RenovoRx (RNXT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $3.00 price target on the stock.
Low
Report
RenovoRx (RNXT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $3.00 price target on the stock.
4/8
08:30 am
rnxt
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
Medium
Report
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
4/4
01:04 am
rnxt
Medium
Report
4/1
03:20 pm
rnxt
RenovoRx Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026 [Yahoo! Finance]
Low
Report
RenovoRx Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026 [Yahoo! Finance]
4/1
02:20 pm
rnxt
RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
Low
Report
RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
3/30
11:11 pm
rnxt
RenovoRx Inc (RNXT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
Medium
Report
RenovoRx Inc (RNXT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
5/15/2025
04:05 pm
rnxt
renovorx, inc.
IN-LINE
Report
5.4%
renovorx, inc.
4/16
05:10 pm
rnxt
Form S-3 RenovoRx, Inc.
Neutral
Report
Form S-3 RenovoRx, Inc.
4/9
10:19 am
rnxt
Form D RenovoRx, Inc.
Medium
Report
Form D RenovoRx, Inc.
4/7
08:02 pm
rnxt
Form 4 RenovoRx, Inc. For: Apr 03 Filed by: Bagai Shaun
Low
Report
Form 4 RenovoRx, Inc. For: Apr 03 Filed by: Bagai Shaun
4/7
08:01 pm
rnxt
Form 4 RenovoRx, Inc. For: Apr 03 Filed by: VOLL MARK
Low
Report
Form 4 RenovoRx, Inc. For: Apr 03 Filed by: VOLL MARK
4/7
08:00 pm
rnxt
Form 4 RenovoRx, Inc. For: Apr 03 Filed by: Gentry Leesa
Low
Report
Form 4 RenovoRx, Inc. For: Apr 03 Filed by: Gentry Leesa
4/7
08:00 pm
rnxt
Form 4 RenovoRx, Inc. For: Apr 03 Filed by: Agah Ramtin
Low
Report
Form 4 RenovoRx, Inc. For: Apr 03 Filed by: Agah Ramtin
3/31
04:20 pm
rnxt
Form S-8 RenovoRx, Inc.
Medium
Report
Form S-8 RenovoRx, Inc.
3/30
05:42 pm
rnxt
Form 8-K RenovoRx, Inc. For: Mar 30
Medium
Report
Form 8-K RenovoRx, Inc. For: Mar 30
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register